TARINTIS Trademark
Trademark Overview
On Thursday, May 30, 2024, a trademark application was filed for TARINTIS with the United States Patent and Trademark Office. The USPTO has given the TARINTIS trademark a serial number of 98576689. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, June 2, 2026. This trademark is owned by Pfizer Inc.. The TARINTIS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
General Information
| Serial Number | 98576689 |
| Word Mark | TARINTIS |
| Filing Date | Thursday, May 30, 2024 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Tuesday, June 2, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 26, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 30, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Pfizer Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10001-2192
US |
| Party Name | Pfizer Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10001-2192
US |
Trademark Events
| Event Date | Event Description |
| Thursday, May 30, 2024 | NEW APPLICATION ENTERED |
| Wednesday, August 14, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 30, 2024 | ASSIGNED TO EXAMINER |
| Friday, November 1, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 20, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 26, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 26, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 7, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, May 30, 2025 | SOU TEAS EXTENSION RECEIVED |
| Friday, May 30, 2025 | SOU EXTENSION 1 FILED |
| Friday, May 30, 2025 | SOU EXTENSION 1 GRANTED |
| Monday, September 15, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, December 1, 2025 | SOU TEAS EXTENSION RECEIVED |
| Monday, December 1, 2025 | SOU EXTENSION 2 FILED |
| Monday, December 1, 2025 | SOU EXTENSION 2 GRANTED |
| Tuesday, December 2, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, January 30, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, January 30, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, January 30, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, January 30, 2026 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Tuesday, May 12, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, May 12, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, May 12, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, May 12, 2026 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Monday, June 1, 2026 | SOU TEAS EXTENSION RECEIVED |
| Monday, June 1, 2026 | SOU EXTENSION 3 FILED |
| Tuesday, June 2, 2026 | SOU EXTENSION 3 GRANTED |
| Tuesday, June 2, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
